News
Most active fund managers underperform the market for 11th straight year
Stocks that are out of favor can sometimes see short-term gains, while the opposite is true for those that have seen aggressive buying.
IBM’s AI may lead to new antimicrobials, drugs, and materials
March 12, 2021
source: venturebeat.com
Researchers at IBM say they’ve developed an AI model that can assist in the rapid design of antimicrobial peptides — the building blocks of proteins.
Global stocks, oil edge away from highs as stimulus rally ebbs
March 12, 2021
source: finance.yahoo.com
Global shares were flat on Friday but within sight of a record high, while oil edged lower as benchmark debt yields climbed, helping to curb the latest stimulus-driven rally.
Turns out, "calling it from the gut," may become a strategy of the past as data increasingly drives decision-making. But how will these data-driven approaches change investment teams?
Many analysts and investors believe the valuations of some of the highest-flying growth stocks have become stretched at this point, limiting additional upside in the near term.
The field of artificial intelligence moves swiftly, with the pace of innovation only accelerating.
Stock traders don't normally talk about bond auctions, but all this week the 10-year Treasury auction that will happen on Wednesday has been the main subject of conversation.
Researchers find that large language models struggle with math
March 10, 2021
source: venturebeat.com
It’s revealing, then, that as sophisticated as machine learning models are today, even state-of-the-art models struggle to answer the bulk of math problems correctly.
Elucidate, the Berlin-based financial crime risk quantification agency, has raised €2.5 million in a pre-Series-A funding round led by Frontline Ventures.
